Images List Premium Download Classic

Skin Diseases

Skin Diseases-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Method of manufacturing corticosteriod containing foam compositions
Therapeutics Incorporated
May 24, 2018 - N°20180140615

The present invention provides a method of manufacturing foamable, corticosteroid containing compositions as well as methods for treating various skin diseases.. .
Corticosteriod containing foam compositions
Therapeutics Incorporated
May 24, 2018 - N°20180140614

The present invention provides a method of manufacturing foamable, corticosteroid containing compositions as well as methods for treating various skin diseases.. .
Isolated peptides and fragments thereof from fibrinogen for use as drugs, particuarly in skin inflammatory ...
Institut Gustave-roussy
April 19, 2018 - N°20180105574

A present invention relates to isolated peptides obtained from human fibrinogen for their use as drug, particularly for the prevention and/or the treatment of inflammatory skin diseases, more particularly acne. The present invention also relates to fragments of these polypeptides, nucleic acid molecules encoding them, expression vectors, host cells, a pharmaceutical composition and a combination product containing them, and ...
Skin Diseases Patent Pack
Download + patent application PDFs
Skin Diseases Patent Applications
Download + Skin Diseases-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Skin Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pharmaceutical compound
Vallaurix Pte. Ltd.
April 05, 2018 - N°20180094039

The present invention relates to compounds comprising a quaternary ammonium group, their use in skin diseases, and their preparation.. .
Topical anti-inflammatory pharmaceutical composition with zileuton cream formulation
Qurient Co., Ltd.
April 05, 2018 - N°20180092877

Provided herein is a zileuton cream type topical anti-inflammatory pharmaceutical composition, and more particularly, a zileuton cream type topical anti-inflammatory pharmaceutical composition capable of retaining stability at room temperature and of being applied topically to maximize medical effects while minimizing absorption to an entirety of body, thereby minimizing toxicity caused by the compound so as to be suitable to topical ...
Pharmaceutical compound
Vallaurix Pte. Ltd.
March 29, 2018 - N°20180086789

The present invention relates to an alpha-msh analogue compound, the use in skin diseases, and the preparation.. .
Skin Diseases Patent Pack
Download + patent application PDFs
Skin Diseases Patent Applications
Download + Skin Diseases-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Skin Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Composition for diagnosing skin damage caused by fine dust, and composition comprising galangin as active ...
Amorepacific Corporation
February 15, 2018 - N°20180044734

The present specification discloses a biomarker for diagnosing skin cell damage caused by fine dust, a kit using the same, and a novel use of a composition comprising galangin as an active ingredient. Specifically, it is possible to conveniently check skin damage caused by fine dust by measuring and comparing the expression amounts of the biomarker in normal cells and ...
Antibacterial clay compositions for use as a topical ointment
Bishopsgate Exploration Ltd.
January 25, 2018 - N°20180021374

The present invention is directed to synthetic bactericidal compositions having clay like properties and a method of using these compositions to topically treat bacterially-caused skin infections and skin diseases. The compositions within the scope of the invention comprise a bactericidal effective amount of a reducing agent, such as pyrite, marcasite, pyrrhotite, fes2, fes, feso4—or other reducing agents having ...
Use of isothiocyanate functional surfactants as nrf2 inducers to treat epidermolysis bullosa simplex and related ...
January 18, 2018 - N°20180016229

The present invention relates to methods and compositions for the prevention and treatment of keratin-based skin diseases. In particular, the application describes compositions and methods of treating a patient suffering from skin blistering comprising the use of phase ii enzyme inducers and/or activity modifiers..
Pterostilbene (pter) for use in the prevention and/or treatment of skin diseases, damages or ...
Green Molecular, S.l.
January 11, 2018 - N°20180008555

The present invention refers to the use of pter, or any acceptable salt thereof, optionally in combination with quer, or any acceptable salt thereof, for the manufacture of pharmaceutical compositions for preventing and/or treating skin diseases, damages or injuries. Those methods of prevention and/or treatment comprise the administration of an effective amount of a composition comprising pter as ...
Topical formulations comprising a steroid
Dr. Reddy's Laboratories Ltd.
December 21, 2017 - N°20170360808

The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and ...
Cosmetic composition for improving condition of skin, containing cell culture medium, epidermal growth factor and ...
Biocoz Global Korea Corp.
December 14, 2017 - N°20170355952

The present invention relates to: a cosmetic composition for improving the condition of the skin, containing, as active ingredients, a cell culture medium, an epidermal growth factor and a bovine serum albumin; a method for improving the condition of the skin by using the same; and a method for preventing or treating skin diseases. According to the present invention, the ...
Preventing and treating inflammatory skin diseases
Tel Hashomer Medical Research Infrastructure And Services Ltd.
November 23, 2017 - N°20170335328

The present invention relates to methods of treating, preventing, reducing the severity of, reducing the incidence of, delaying the onset of, or reducing pathogenesis of an inflammatory skin disease, condition or lesion in a human subject, which include the step of administering to the subject a therapeutically effective amount of mi rna compositions. In addition, methods of this invention may ...
Skin Diseases Patent Pack
Download + patent application PDFs
Skin Diseases Patent Applications
Download + Skin Diseases-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Skin Diseases-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
High throughput sequencing
October 26, 2017 - N°20170306404

The invention relates to a high throughput method for determining telomere length of mammalian chromosomal dna; primers for use in said method; a kit comprising said primers; use of said method to diagnose or prognose or to determine the risk of developing a telomere shortening disease such as cancer, ageing, neurological disorders including alzheimer's disease, parkinson's disease and other dementias, ...
Therapeutic or prophylactic agent for itching skin diseases
Toray Industries, Inc.
October 05, 2017 - N°20170281727

An antimicrobial peptide ll-37 has an action to promote expression of a nerve repulsion factor sema3a. Ll-37 is a peptide composed of the c-terminal 37 residues of human cathelicidin hcap18.
Benzoxazinone derivatives for treatment of skin diseases
Sixera Pharma Ab
September 21, 2017 - N°20170267692

The present invention relates to methods and compositions for inhibiting the activity of skin proteases, especially human kallikrein 7 (klk7), human kallikrein 5 (klk5), and human kallikrein 14 (klk14). More specifically, the invention relates to the use of substituted 3,1-benzoxazin-4-ones being selective inhibitors of human skin kallikreins for the treatment of skin diseases, more specifically for the treatment of inflammatory skins diseases, ...
Topical formulations comprising a steroid
Dr. Reddy's Laboratories Ltd.
September 14, 2017 - N°20170258813

The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and ...
Modulating gamma-c-cytokine activity
Bioniz, Llc
August 24, 2017 - N°20170240607

Peptide antagonists of γc-family cytokines, which is associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools.
Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
Bioniz, Llc
July 20, 2017 - N°20170204153

The γc-family cytokines, interleukin-2 (il-2), interleukin-4 (il-4), interleukin-7 (il-7), interleukin-9 (il-9), interleukin-15 (il-15), and interleukin-21 (il-21), are associated with important human diseases, such as leukemia, autoimmune diseases, collagen diseases, diabetes mellitus, skin diseases, degenerative neuronal diseases and graft-versus-host disease (gvhd). Thus, inhibitors of γc-cytokine activity are valuable therapeutic and cosmetic agents as well as research tools.
Composition comprising gpcr19 agonist as an active ingredient for preventing or treating allergic dermatitis
Shaperon Inc.
July 13, 2017 - N°20170196895

The present invention is about a pharmaceutical composition, an oral preparation, and an injection preparation containing a g protein-coupled receptor19 (gpcr19) agonist, specifically sodium taurodeoxycholate(hy2191) and its derivative, as an active ingredient for preventing or treating allergic skin diseases. The present invention is also about an external preparation and a cosmetic composition containing said pharmaceutical composition for preventing and ...
Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
Aobiome Llc
July 06, 2017 - N°20170191109

This disclosure provides, inter alia, systems and methods for testing products for ammonia oxidizing bacteria, quality control, and providing products with ammonia oxidizing bacteria. The systems and methods herein may be used, inter alia, to treat diseases associated with low nitrite levels, skin diseases, and diseases caused by pathogenic bacteria..
Loading